Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the earlier phase (Alpha and Beta Phase B1):
- People aged 18 or older who are able to follow all study procedures and can give written consent to participate
- People who have been diagnosed with either Essential Tremor (ET) or Parkinson's Disease (PD) based on their medical history
- People who experience moderate to severe tremor (shaking) in one or both arms
For the later phase (Beta Phase B2):
- People aged 18 or older who are able to follow all study procedures and can give written consent to participate
- People with Essential Tremor where the diagnosis has been confirmed as "definite" or "probable" using a standard medical classification system, or people with Parkinson's Disease diagnosed by a movement disorder specialist
- People with Essential Tremor where at least one hand shows a tremor level above a certain threshold, as measured during specific tasks at a screening visit (confirm with trial site)
- People with Parkinson's Disease where tremor in the arms or hands scores above a certain level on a standard assessment scale at the screening visit (confirm with trial site)
- People who score above a certain level on at least one everyday activity that tremor makes difficult — such as using a spoon, holding a cup, doing up buttons or a zipper, or writing a letter
- People whose tremor medications have remained unchanged for at least 30 days before joining and who are able to keep taking the same medications throughout the study
- People with Parkinson's Disease who are able to attend study visits after stopping all tremor medications for 12 hours beforehand
- People with a wrist measurement between 6.0 and 8.1 inches
Who may not be able to join:
- People who are pregnant
- People who have swelling, infection, inflammation, open wounds, skin rashes, or cancerous skin lesions at the area where the device would be applied
- People with a history of psoriasis, eczema, or atopic dermatitis at the area where the device would be applied
- People with a history of nerve damage or nerve conditions in the arms or hands, including carpal tunnel syndrome or diabetic neuropathy
- People who are unable to communicate with the study team
- People with any other medical, physical, or mental health condition that the study team considers would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ann Marie Murray, MD, WVU Comprehensive Movement Disorder Clinic
Phone: 855-937-5302
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess the design changes between the alpha and beta versions of the device; To assess the usability of the beta device in an at-home setting
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.